Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POISE-3 Trial
2018-000539-29Phase 3Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in perioperative bleeding, arterial thrombosis and Phlebothrombosis (4 arms), sponsored by Hamilton Health Sciences. Primary endpoint: Composite bleeding outcome. Started Nov 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
perioperative bleedingarterial thrombosisPhlebothrombosis
Beyond the preview
Go deeper on 2018-000539-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000539-29.